505 related articles for article (PubMed ID: 16945991)
1. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
Al-Khalili L; Bouzakri K; Glund S; Lönnqvist F; Koistinen HA; Krook A
Mol Endocrinol; 2006 Dec; 20(12):3364-75. PubMed ID: 16945991
[TBL] [Abstract][Full Text] [Related]
2. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
3. Creatine supplementation increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells.
Ceddia RB; Sweeney G
J Physiol; 2004 Mar; 555(Pt 2):409-21. PubMed ID: 14724211
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor γ decouples fatty acid uptake from lipid inhibition of insulin signaling in skeletal muscle.
Hu S; Yao J; Howe AA; Menke BM; Sivitz WI; Spector AA; Norris AW
Mol Endocrinol; 2012 Jun; 26(6):977-88. PubMed ID: 22474127
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.
Carey AL; Steinberg GR; Macaulay SL; Thomas WG; Holmes AG; Ramm G; Prelovsek O; Hohnen-Behrens C; Watt MJ; James DE; Kemp BE; Pedersen BK; Febbraio MA
Diabetes; 2006 Oct; 55(10):2688-97. PubMed ID: 17003332
[TBL] [Abstract][Full Text] [Related]
6. Activation of AMP-activated protein kinase, inhibition of pyruvate dehydrogenase activity, and redistribution of substrate partitioning mediate the acute insulin-sensitizing effects of troglitazone in skeletal muscle cells.
Fediuc S; Pimenta AS; Gaidhu MP; Ceddia RB
J Cell Physiol; 2008 May; 215(2):392-400. PubMed ID: 17960559
[TBL] [Abstract][Full Text] [Related]
7. Role of AMP-activated protein kinase in the coordinated expression of genes controlling glucose and lipid metabolism in mouse white skeletal muscle.
Long YC; Barnes BR; Mahlapuu M; Steiler TL; Martinsson S; Leng Y; Wallberg-Henriksson H; Andersson L; Zierath JR
Diabetologia; 2005 Nov; 48(11):2354-64. PubMed ID: 16237515
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle.
Glund S; Deshmukh A; Long YC; Moller T; Koistinen HA; Caidahl K; Zierath JR; Krook A
Diabetes; 2007 Jun; 56(6):1630-7. PubMed ID: 17363741
[TBL] [Abstract][Full Text] [Related]
9. Eicosapentaenoic acid (20:5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells.
Aas V; Rokling-Andersen MH; Kase ET; Thoresen GH; Rustan AC
J Lipid Res; 2006 Feb; 47(2):366-74. PubMed ID: 16301737
[TBL] [Abstract][Full Text] [Related]
10. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
[TBL] [Abstract][Full Text] [Related]
11. Gly-Ala-Gly-Val-Gly-Tyr, a novel synthetic peptide, improves glucose transport and exerts beneficial lipid metabolic effects in 3T3-L1 adipoctyes.
Kim ED; Kim E; Lee JH; Hyun CK
Eur J Pharmacol; 2011 Jan; 650(1):479-85. PubMed ID: 20951125
[TBL] [Abstract][Full Text] [Related]
12. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle.
Lee WJ; Song KH; Koh EH; Won JC; Kim HS; Park HS; Kim MS; Kim SW; Lee KU; Park JY
Biochem Biophys Res Commun; 2005 Jul; 332(3):885-91. PubMed ID: 15913551
[TBL] [Abstract][Full Text] [Related]
13. PPARdelta activator GW-501516 has no acute effect on glucose transport in skeletal muscle.
Terada S; Wicke S; Holloszy JO; Han DH
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E607-11. PubMed ID: 16278250
[TBL] [Abstract][Full Text] [Related]
14. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates.
Jobgen WS; Fried SK; Fu WJ; Meininger CJ; Wu G
J Nutr Biochem; 2006 Sep; 17(9):571-88. PubMed ID: 16524713
[TBL] [Abstract][Full Text] [Related]
15. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.
Tomas E; Tsao TS; Saha AK; Murrey HE; Zhang Cc Cc; Itani SI; Lodish HF; Ruderman NB
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16309-13. PubMed ID: 12456889
[TBL] [Abstract][Full Text] [Related]
16. JNK deficiency enhances fatty acid utilization and diverts glucose from oxidation to glycogen storage in cultured myotubes.
Vijayvargia R; Mann K; Weiss HR; Pownall HJ; Ruan H
Obesity (Silver Spring); 2010 Sep; 18(9):1701-9. PubMed ID: 20094041
[TBL] [Abstract][Full Text] [Related]
17. Regulation of skeletal muscle sucrose, non-fermenting 1/AMP-activated protein kinase-related kinase (SNARK) by metabolic stress and diabetes.
Rune A; Osler ME; Fritz T; Zierath JR
Diabetologia; 2009 Oct; 52(10):2182-9. PubMed ID: 19652946
[TBL] [Abstract][Full Text] [Related]
18. Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study.
Jucker BM; Yang D; Casey WM; Olzinski AR; Williams C; Lenhard SC; Legos JJ; Hawk CT; Sarkar SK; Newsholme SJ
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1256-64. PubMed ID: 17726146
[TBL] [Abstract][Full Text] [Related]
19. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.
Krämer DK; Al-Khalili L; Guigas B; Leng Y; Garcia-Roves PM; Krook A
J Biol Chem; 2007 Jul; 282(27):19313-20. PubMed ID: 17500064
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.
Yoon MJ; Lee GY; Chung JJ; Ahn YH; Hong SH; Kim JB
Diabetes; 2006 Sep; 55(9):2562-70. PubMed ID: 16936205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
